Dimensional Fund Advisors LP Altimmune, Inc. Transaction History

Dimensional Fund Advisors LP

$405 Billion
Q4 2024

A detailed history of Dimensional Fund Advisors LP transactions in Altimmune, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 633,441 shares of ALT stock, worth $4.04 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

633,441

Previous 646,377 2.0%

Holding current value

$4.04 Million

Previous $3.97 Million 15.1%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$6.02 - $9.85 $77,874 - $127,419	-12,936 Reduced 2.0%	633,441 $4.57 Million
Q3 2024 Nov 07, 2024	BUY	$5.5 - $8.1 $419,116 - $617,244	76,203 Added 13.36%	646,377 $3.97 Million
Q2 2024 Aug 09, 2024	BUY	$5.91 - $10.23 $1.98 Million - $3.43 Million	335,444 Added 142.91%	570,174 $3.79 Million
Q1 2024 May 10, 2024	SELL	$8.22 - $13.81 $220,197 - $369,942	-26,788 Reduced 10.24%	234,730 $2.39 Million
Q4 2023 Feb 07, 2024	BUY	$2.14 - $11.62 $154,651 - $839,742	72,267 Added 38.19%	261,518 $2.94 Million
Q3 2023 Nov 09, 2023	SELL	$2.4 - $3.45 $160,807 - $231,160	-67,003 Reduced 26.15%	189,251 $492,000
Q2 2023 Aug 09, 2023	SELL	$3.45 - $5.97 $1.07 Million - $1.85 Million	-310,247 Reduced 54.77%	256,254 $904,000
Q1 2023 May 12, 2023	BUY	$4.19 - $16.83 $1.63 Million - $6.54 Million	388,636 Added 218.5%	566,501 $2.39 Million
Q4 2022 Feb 09, 2023	BUY	$8.74 - $16.45 $30,520 - $57,443	3,492 Added 2.0%	177,865 $2.93 Million
Q3 2022 Nov 10, 2022	BUY	$10.67 - $22.41 $544,266 - $1.14 Million	51,009 Added 41.35%	174,373 $2.23 Million
Q2 2022 Aug 12, 2022	BUY	$3.94 - $11.77 $199,608 - $596,291	50,662 Added 69.68%	123,364 $1.44 Million
Q1 2022 May 13, 2022	SELL	$5.9 - $9.45 $34,031 - $54,507	-5,768 Reduced 7.35%	72,702 $443,000
Q4 2021 Feb 09, 2022	BUY	$8.69 - $12.48 $681,904 - $979,305	78,470 New	78,470 $719,000

Others Institutions Holding ALT

# of Institutions

208

Shares Held

39.5M

Call Options Held

1.94M

Put Options Held

1.38M

View Full List

About Altimmune, Inc.

Ticker ALT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,025,300
Market Cap $312M
Description
Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatit...

More about ALT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Account

Dimensional Fund Advisors LP Altimmune, Inc. Transaction History